Arbevel
VC Fund
Paris, France
Arbevel is an independent and entrepreneurial management company, Financière Arbevel has become a reference in the small and mid caps segment.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Arbevel invests in
Stages Arbevel invests in
Countries Arbevel invests in
Round sizes
Round size
- Series A
- $6.5M–$18M
- Series C
- $14M–$47M
- Debt Financing
- $4.3M–$77M
Investment Focus
Industry
- Health Care 6 (33%)
- Medical 5 (28%)
- Biotechnology 3 (17%)
- Medical Device 2 (11%)
- News 1 (6%)
Stage
- Series A 4 (22%)
- Series C 3 (17%)
- Debt Financing 3 (17%)
- Venture - Series Unknown 3 (17%)
- Series B 2 (11%)
Country
- France 12 (67%)
- Israel 1 (6%)
- United States 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Germitec SAS
|
Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system. | $30.1M / Series B / Feb 12, 2025 | |
Karmen
|
Karmen offers non-dilutive financing solutions that enable digital businesses to access capital quickly and flexibly. The platform allows companies to secure funds for various needs, such as customer acquisition, recruitment, and inventory financing, with a streamlined online process. | Debt Financing / Jan 21, 2025 | |
UroMems
|
UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. | $47.1M / Series C / Jun 25, 2024 | |
SoMeD Sante
|
SoMeD Santé is a private French health centre and management facilities group, providing dental, medical, paramedic and radiology care. | $4.3M / Debt Financing / Feb 09, 2024 | |
Kalray
|
KALRAY is a fabless semiconductor and software company that develops, markets & sells a new generation of manycore processors for Imaging, Telecommunication infrastructures, Data Security & Network Appliances embedded applications. | $25.7M / Post-IPO Equity / Dec 02, 2022 | |
Kalray
|
Kalray is an intelligent Data Processing from Cloud to Edge. | $26.8M / Dec 01, 2022 | |
Eovolt
|
Eovolt is a French brand that specializes in folding, lightweight, and ultra-compact electric bike. Eovolt bikes are ideal for motorhomes, boat owners or just for city-dwellers allowing them to travels easier enjoy cycling while optimizing your space. It was founded in 2018. | $16.2M / Venture - Series Unknown / Sep 12, 2022 | |
|
Germitec SAS
|
Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system. | $11.6M / Venture - Series Unknown / May 10, 2022 | |
MEXBRAIN
|
MexBrain is a biotechnology company based on extracting metals from the human body. They create medical equipment that can extract metals precisely, quickly, and under control. Additionally, they combine the two technologies of nanotechnology and dialysis. This increases the treatment's efficacy and enables everyone to benefit from bothworlds. | $6.9M / Series A / May 06, 2021 | |
|
UroMems
|
UroMems is innovative per se and focuses on clearly identified clinical needs, for their prevalence, but also for their negative impact on patients’ quality of life. | $8.3M / Series B / Apr 06, 2021 | |
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Arbevel invest in?
Arbevel invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series C stage. Most of the 18 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Arbevel's check size?
Arbevel typically joins rounds of $6.5M–$18M at Series A, $14M–$47M at Series C and $4.3M–$77M at Debt Financing. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Arbevel participates in.
When did Arbevel last invest?
The most recent investment recorded for Arbevel closed in Feb 2025. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
